TRISOMY 8 IN HIGH RISK MDS PATIENT
a Cancer Citogenomic Laboratory (LCC), Universidade Federal do Ceará (UFC), Fortaleza, Brazil
b Pos-Graduate Program in Medical Sciences, Universidade Federal do Ceará (UFC), Fortaleza, Brazil
c Pos-Graduate Program in Pathology, Universidade Federal do Ceará (UFC), Fortaleza, Brazil
d Department of Clinical Medicine, Universidade Federal do Ceará (UFC), Fortaleza, Brazil
Lido
1083
Vezesque se leu este artigo
366
Total PDF
717
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 22 | 9 | 31 |
| 2025 5 | 71 | 9 | 80 |
| 2025 4 | 46 | 14 | 60 |
| 2025 3 | 69 | 14 | 83 |
| 2025 2 | 42 | 12 | 54 |
| 2025 1 | 40 | 22 | 62 |
| 2024 12 | 34 | 16 | 50 |
| 2024 11 | 48 | 17 | 65 |
| 2024 10 | 34 | 23 | 57 |
| 2024 9 | 46 | 16 | 62 |
| 2024 8 | 38 | 15 | 53 |
| 2024 7 | 44 | 30 | 74 |
| 2024 6 | 38 | 24 | 62 |
| 2024 5 | 39 | 29 | 68 |
| 2024 4 | 27 | 15 | 42 |
| 2024 3 | 20 | 19 | 39 |
| 2024 2 | 19 | 17 | 36 |
| 2024 1 | 16 | 14 | 30 |
| 2023 12 | 10 | 22 | 32 |
| 2023 11 | 10 | 25 | 35 |
| 2023 10 | 4 | 4 | 8 |
Mostrar tudo
